THERACLION (EPA:ALTHE) | WebDisclosure

Basculer en Français

10603	Companies
225009	Keywords
153732	Articles
119071	Press releases

Home
Companies
THERACLION

PRESS RELEASE

published on 07/25/2025 at 18:30, 10 months 26 days ago

Informations privilégiées / Communiqué sur comptes, résultats
Theraclion annonce une progression significative au premier semestre 2025, avec une hausse des ventes de consommables, l'expansion en Bulgarie et Espagne, l'accélération de la commercialisation et des avancées dans l'essai clinique FDA

FDA Commercialisation Ventes Progression Theraclion
BRIEF

published on 07/09/2025 at 18:35, 11 months 11 days ago

Review of the first half of 2025 of the Theraclion liquidity contract

Liquidity Contract Half-yearly Report Euronext Growth Theraclion Securities Traded
BRIEF

published on 07/09/2025 at 18:35, 11 months 11 days ago

Bilan du premier semestre 2025 du contrat de liquidité de Theraclion

Contrat De Liquidité Bilan Semestriel Euronext Growth Theraclion Titres Échangés
PRESS RELEASE

published on 07/09/2025 at 18:30, 11 months 11 days ago

Informations privilégiées / Autres communiqués
Présentation du bilan du premier semestre 2025 du contrat de liquidité entre Theraclion et le Crédit Industriel et Commercial, incluant les chiffres clés des transactions. Informations sur Theraclion, société de MedTech développant une alternative non invasive à la chirurgie

Contrat De Liquidité MedTech Bilan SONOVEIN Ultrasons Focalisés
BRIEF

published on 02/20/2025 at 18:35, 1 year 4 months ago

Theraclion sécurise un financement via un emprunt obligataire convertible

Financement Obligations Convertibles Stratégie Commerciale Theraclion R&D Et FDA
BRIEF

published on 02/20/2025 at 18:35, 1 year 4 months ago

Theraclion secures financing via a convertible bond issue

Convertible Bonds Funding Business Strategy Theraclion R&D And FDA
PRESS RELEASE

published on 02/20/2025 at 18:30, 1 year 4 months ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial

Actionnaires Financement Emprunt Theraclion Obligataire Convertible
PRESS RELEASE

published on 02/20/2025 at 18:30, 1 year 4 months ago

Inside Information / Operations of the issuer (acquisitions, sales...)
Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval

Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
BRIEF

published on 02/07/2025 at 18:35, 1 year 4 months ago

Publication of Theraclion's adjusted accounts for the first half of 2024

Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
BRIEF

published on 02/07/2025 at 18:35, 1 year 4 months ago

Publication des comptes ajustés de Theraclion pour le premier semestre 2024

Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices

Accesswire

Published on 06/20/2026 at 01:00, 19 hours 7 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 20 hours 7 minutes ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 15 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 18 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 19 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 06:00, 14 hours 6 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 23 hours 49 minutes ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 23 hours 49 minutes ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 1 hour ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 1 day 1 hour ago

Designated Person Notification

Les Echos

Published on 06/19/2026 at 19:33, 1 day ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 1 hour ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE